Source: PR NEWSWIRE

Press Release: Max Neeman : Regulatory Draft Guidelines Address Clinical Trial Compensation for Medical Management in India

RESEARCH TRIANGLE PARK, N.C., June 9, 2014 /PRNewswire/ -- Max Neeman International announced today that India's Ministry of Health released new and revised draft guidelines on compensation to be paid for medical management with regards to treatment of any injury related to clinical...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Ajoy Kuma's photo - CEO of Max Neeman

CEO

Ajoy Kuma

CEO Approval Rating

70/100

Read more